ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2011

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity.

S M Rudman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.